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Regulation of vitamin D-1-hydroxylase in a human cortical actions. Classically, 1,25(OH)2D3 plays an essential role
collecting duct cell line. in maintaining serum calcium homeostasis by modulating
Background. Recent studies have shown that renal expres- calcium/phosphate absorption. Synthesis of 1,25(OH)2D3sion of 25-hydroxyvitamin D3-1-hydroxylase (1-OHase) is
from the major circulating form of vitamin D, 25-hydro-not restricted to proximal tubules. To investigate the signifi-
cance of this expression, we characterized the regulation of xyvitamin D3, is catalyzed by the enzyme 25-hydroxyvi-
1-OHase expression and activity in a human cortical collecting tamin D3-1-hydroxylase (1-OHase) a mitochondrial
duct cell line (HCD). cytochrome P450 enzyme [1]. The renal synthesis of
Methods. Expression of 1-OHase mRNA and protein was
1,25(OH)2D3 is tightly regulated by complex interactionsassessed by reverse transcription-polymerase chain reaction
between parathyroid hormone (PTH), calcium, phosphate,(RT-PCR) and Western blot analyses. Enzyme activity was quan-
tified using 25-hydroxyvitamin D3 as the substrate; conversion and 1,25(OH)2D3 itself [2–7]. Until recently, analysis of
to 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and 24,25-dihy- the regulation of 1-OHase in normal physiology has been
droxyvitamin D3 was then determined by thin-layer chromatog- severely restricted because synthesis of 1,25(OH)2D3 couldraphy.
be detected only in conditions of vitamin D deficiency.Results. HCD cells expressed mRNA and protein for 1-
OHase. However, basal 1,25(OH)2D3 production was lower However, studies of the mechanisms involved in regulat-
than that observed in proximal tubule HKC-8 cells. In both ing 1,25(OH)2D3 availability at both local and systemic
cell lines, synthesis of 1,25(OH)2D3 was increased by forskolin, levels have been greatly facilitated by the recent cloningparathyroid hormone, and low calcium medium. Conversely,
of human, rat, mouse and pig cDNAs for 1-OHase [8–13].treatment with 1,25(OH)2D3 itself decreased 1-OHase activ-
ity. This effect was more pronounced in HCD cells, which Various studies have indicated that the proximal convo-
also demonstrated significantly higher levels of 24-hydroxylase luted tubules (PCT) are the principal site of 1,25(OH)2D3
activity. The most striking induction of 1-OHase activity was production [14, 15], although extrarenal production also
observed in the HCD cells following incubation with lipopoly-
has been documented [16]. However, in recent immuno-saccharide, which was coincident with the expression of mRNA
histochemistry and in situ hybridization studies, we havefor both CD14 and Toll-like receptor 4.
Conclusions. These results highlight the capacity for synthe- demonstrated that renal expression of 1-OHase is not
sis of 1,25(OH)2D3 in cells from more distal areas of the neph- restricted to the PCT. mRNA and protein are abundantly
ron. However, more sensitive feedback regulation and immune
expressed in more distal areas of the nephron, includinginduction of 1-OHase in the HCD cells suggest a more local-
the distal convoluted tubule, cortical collecting ductsized role for 1,25(OH)2D3 production in the distal nephron.
(CCD), medullary collecting duct, thick ascending loop
of Henle, and papillary epithelium [17]. To investigate
the significance of 1,25(OH)2D3 production in the distalThe active form of vitamin D, 1,25-dihydroxyvitamin
nephron, we have characterized the expression and regu-D3 [1,25(OH)2D3], is a steroid hormone with pleiotropic
lation of 1-OHase in an SV40-transformed human CCD
line (HCD) [18]. Analysis of vitamin D metabolism in
Key words: distal nephron, steroid hormone, calcium homeostasis,
these cells was carried out in parallel with studies of theparathyroid hormone, HKC-8 cell line, HCD cell line, vitamin D metab-
olism, immunosuppression. SV40-transformed PCT cell line HKC-8, which we have
shown previously to be an excellent model for renal
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of vitamin D metabolism. In particular, we investigated scanner (Bioscan Inc., Edmonds, WA, USA). Residual
cell monolayers from parallel wells were lysed and as-a putative immunomodulatory role for renal 1-OHase
by analyzing the effects of lipopolysaccharide (LPS) on sayed for total cellular protein using a Bio-Rad protein
assay (Bio-Rad, Melville, NY, USA).vitamin D metabolism in HCD and HKC-8 cells. Parallel
analysis of the related cytochrome P450, 25-hydroxyvi-
Experimental treatmentstamin D3-24-hydroxylase (24-OHase), also was carried
out to assess the coordinated function of these enzymes Cells maintained in the presence of FCS were trans-
ferred to defined medium 24 hours prior to treatments.along the nephron.
Cells were treated with forskolin (10mol/L), 1,25(OH)2D3
(10 nmol/L), bioactive (1-34) human parathyroid hor-
METHODS
mone (PTH; 100 ng/mL), calcitonin (100 mol/L; bovine
Cell culture thyrocalcitonin,) for 24 hours, or low medium calcium
concentrations (0.5 mmol/L; 4 to 48 h), or lipopolysac-Human collecting duct cells were derived from normal
human kidney cortex and were immortalized with SV-40 charide (LPS; Escherichia coli, serotype 0111:B4; 1g/mL;
24 or 48 hours). For treatments containing LPS, cellsvirus. Clones were selected using the monoclonal anti-
body, Ab 272, which specifically recognizes collecting were treated in medium containing FCS that was re-
placed with defined medium for the duration of the en-duct principal cells [18]. Both HCD and HKC-8 cells were
maintained as previously described [5, 18]. Briefly, HKC-8 zyme activity assessment. Where indicated, cells were
incubated in calcium-free medium supplemented withcells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM)/Ham’s F-12 (DMEM/F12) medium CaCl2 to give a calcium concentration of 0.5 mmol/L (nor-
mal calcium concentration 1 mmol/L). [3H]-25OHD3 was(GIBCO-BRL, Paisley, Scotland, UK) supplemented with
5% fetal calf serum (FCS; GIBCO-BRL) and 2 mmol/L included for the final four hours. The resulting vitamin
D3 metabolites were extracted and analyzed as describedglutamine (GIBCO-BRL). HCD cells were maintained
in DMEM/F12 medium supplemented with 2% FCS, 2 previously in this article.
mmol/L glutamine, 10 mmol/L HEPES, transferrin (5
Analysis of mRNA expressiong/mL), Na2SeO3 (5 ng/mL), insulin (5 g/mL), and dexa-
methasone (5  108 mol/L). To assess enzyme activity, RNA extraction and reverse transcription. RNA was
prepared from 80% confluent cells by acid-guanidiniummRNA, and protein expression, cells were transferred to
defined medium, which consisted of DMEM/F12 contain- extraction [20]. Reverse transcription (RT) of RNA was
performed using a Promega Reverse Transcription Sys-ing the following additives; glutamine (2 mmol/L), insulin
(5 g/mL), transferrin (5 g/mL), Na2SeO3 (5 ng/mL), tem following an adapted method. Briefly, 1 g of total
RNA and 0.5 g of random hexamers (Promega, Madi-tri-iodothyronine (0.37 nmol/L), epidermal growth factor
(2.5 ng/mL), and hydrocortisone (1 nmol/L; Sigma Chemi- son, WI, USA), in a final volume of 11 L, were incu-
bated at 70C for five minutes and then allowed to coolcal Co., Poole, UK) for 24 hours prior to enzyme assays
or treatments. slowly to 25C. Primer extension was then performed at
37C for 60 minutes following the addition of 1 (final
Measurement of 1- and 24-OHase activity concentration) reaction buffer, containing 50 mmol/L
Tris-HCl (pH 8.3), 50 mmol/L KCl, 10 mmol/L MgCl2,Analysis of hydroxylated metabolites of vitamin D3 was
performed using previously validated thin-layer chroma- 10 mmol/L dithiothreitol (DTT), and 0.5 mmol/L spermi-
dine, 1 mmol/L (final concentration) of each dNTP, 40tography (TLC) methods [5]. Briefly, cells were seeded
in 24-well plates (2  104 per well) and grown to 50% U of rRNAsin ribonuclease inhibitor, and 15 U of AMV
reverse transcriptase in a final volume of 20 L. The RTconfluence before transfer to defined medium (400 L).
Cells were incubated with 3.75 nmol/L [3H]-25OHD3 or mixture was heated to 95C for five minutes then 4C for
five minutes. An aliquot of 5 L was used in subsequent28.75 nmol/L 25OHD3 (1:7.5, [3H]-25OHD3:25OHD3; for
low calcium concentrations shown in Fig. 3) for four polymerase chain reaction (PCR) reactions (2 L for
18S rRNA).hours at 37C. The reaction was terminated by freezing
at 20C. Cell extracts and medium were combined and PCR amplification of cDNAs. Following reverse tran-
scription, amplification of specific cDNAs was carriedvitamin D metabolites were extracted in 2.5 mL of chlo-
roform:methanol (4:1 vol/vol). Following evaporation of out using the primers listed in Table 1. PCR reactions
(20 L) were set up using 1 (final concentration) PCRthe organic phase, steroids were resuspended in 50 L
of dichloromethane and separated on silica TLC plates buffer containing 50 mmol/L KCl, 10 mmol/L Tris-HCl
(pH 9.0) and 0.1% Triton X-100, 1.5 mmol/L MgCl2 (2in dichloromethane:isopropanol (9:1 vol/vol). Standard
lanes were included that contained only [3H]-25OHD3 mmol/L for 18S rRNA), 0.2 mmol/L of each dNTP, 0.5
mol/L of each primer, and 1 U of Taq DNA polymeraseor [3H]-1,25(OH)2D3. Conversion of tritiated steroid was
measured on a Bioscan System 200 imaging TLC plate (Promega). Amplification of samples (Tlr4, CD14, PTHR1,
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Table 1. Polymerase chain reaction (PCR) primers used to amplify 1-OHase, PTHR1, PTHR2, CD14 and Tlr4 mRNA
Annealing Product size
mRNA Primers (5 → 3) Direction temperature bp
1-OHase ACGCTGTTGACCATGGC F 60C 542
GTGACACAGAGTGACCAGCATAT R
PTHR1 AGGGAAGCCCAGGAAAGATA F 58C 364
GGAGTAGCCCACGGTGTAAA R
PTHR2 GAGAGGTTCAGGCAGAGGTG F 55C 547
GCCAATTCATGGAGCCTAAA R
CD14 CACAGGACTTGCACTTTCCA F 51C 507
CTGTTGCAGCTGAGATCGAG R
Tlr4 TGGGAGCCTTTTCTGGACTA F 50C 501
CAATGGTCAAATTGCACAGG R
18S Quantum RNA kit, Ambion Inc., Austin, Texas, USA 50C 488
PTHR2, 18S rRNA) was performed using an initial dena- receptor proteins were detected by the enhanced chemi-
turation step of 95C (5 min) followed by either 30 cycles luminescent assay (ECL; Amersham) after exposure of
(Tlr4, CD14), 35 cycles (PTHR1, PTHR2), or 20 cycles filters to x-ray film for 1 to 20 minutes (VDR and CaR)
(18S rRNA) consisting of one minute of denaturing at and 10 to 30 seconds (1-OHase). Control experiments
95C, one minutes of annealing at required temperature were included where primary antibody was omitted, and
(Table 1), and one minute of extension at 72C. RT-PCR filters were exposed to secondary antibody and ECL
analysis of 1-OHase was as described previously in this detection. An additional control was included for the
article using the following amplification cycle 95C (5 min) 1-OHase antibody, where primary antibody was preab-
followed by 35 cycles of 95C (1 min), 60C (1.5 min), sorbed with an excess of immunizing peptide. No protein
72C (2 min). A final elongation step of 72C for seven bands were detected in these controls (data not shown).
minutes was included in all PCR amplifications.
Data analysis
Western blot analyses Assays for 1-OHase or 24-OHase were carried out in
The preparation of nuclear proteins and total cell ex- triplicate and are reported as the mean SEM of at least
tracts and their subsequent separation by gel electropho- three experiments. Enzyme activities are reported as fmol
resis and electroblotting onto Immobilon P membrane 1,25(OH)2D3 (1-OHase activity) or 24,25(OH)2D3 (24-
were as described previously [5]. Filters were analyzed with OHase activity) produced per hour per mg protein or
(1) specific monoclonal antibodies against the human as mean enzyme induction relative to control values de-
vitamin D receptor (VDR; Cambridge BioScience, Cam- rived from untreated cells. Statistical analysis of data
bridge, UK) and the human calcium-sensing receptor was performed using one-way analysis of variance linked
(CaR; NPS Pharmaceuticals, Salt Lake City, UT, USA) to Tukey-Kramer multiple comparison post-tests (Instat
and (2) polyclonal antiserum to the mouse 1-OHase version 2.04a computer program; GraphPad Software,
sequence (The Binding Site Ltd., Birmingham, UK). San Diego, CA, USA).
Membranes were blocked (1 hour; 25C) in PBS-T (PBS
plus 0.1% Tween-20; Sigma) containing 20% (wt/vol)
RESULTSnonfat milk powder (Marvel, Premier Brands, Stafford,
Initial studies confirmed the expression of 1-OHaseUK) and then rinsed twice in PBS, followed by a further
in both HKC-8 and HCD cells (Fig. 1). RT-PCR analysiswash in PBS-T for 15 minutes. Filters were incubated
revealed similarly sized mRNA transcripts in both cellovernight at 4C with the primary antibody diluted 1:500
lines (Fig. 1A). Subsequent sequence analysis indicated(VDR and 1-OHase) in PBS-T (0.05%) and 160 ng/mL
that the amplified cDNA was identical to that previously(CaR) in PBS-T (0.1%) containing 0.1% nonfat milk
reported for human 1-OHase (data not shown). Simi-(wt/vol). After three 10-minute washes in PBS-T, filters
larly, Western blot analyses identified a single proteinwere incubated with the secondary antibody [horserad-
band of 56 kD in both HKC-8 and HCD cells correspond-ish peroxidase conjugated anti-rat and mouse (VDR and
ing to the predicted size of the 1-OHase protein (Fig.CaR); Amersham, Little Chalfont, UK; anti-sheep (1-
1D) [11]. Levels of expression were slightly higher inOhase); The Binding Site Ltd.] diluted 1:50,000 (VDR),
HKC-8 cells compared with HCD cells. Further RT-1:75,000 (1-OHase) in PBS-T (0.05%), and 1:60,000
PCR analyses demonstrated expression of PTH recep-(CaR) in PBS-T (0.1%) containing 0.1% nonfat milk
tors (type 1 and type 2; Figs. 1 B, C). Western blot(wt/vol) for 90 minutes at 25C (60 min 1-OHase) and
washed for three 10-minute periods in PBS-T. Specific analysis demonstrated the presence of CaR in both cell
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served only with HCD cells (Fig. 2B). In both HCD
and HKC-8 cells, 1-OHase activity was inhibited by
1,25(OH)2D3 (10 nmol/L, 24 hours; Fig. 2 A, B). This
effect appeared to be dose-dependent, but was statisti-
cally significant only at concentrations of 10 nmol/L
1,25(OH)2D3 or higher when an incubation period of 24
hours was used (data not shown). In contrast to the
regulation of 1-OHase, synthesis of 24,25(OH)2D3 was
only stimulated by 1,25(OH)2D3 (Fig. 2 C, D).
HKC-8 and HCD cells incubated in medium con-
taining low calcium (0.5 mmol/L) showed rapid stimula-
tion of 1-OHase activity in both HKC-8 and HCD cells
(Fig. 3A). In both cell lines, the induction of 1,25(OH)2D3
production was rapid, with maximal stimulation observed
after four hours. However, in HKC-8 cells, stimulation
by low calcium was transient, and 1,25(OH)2D3 produc-
tion had returned to basal levels after 24 hours. In con-
trast, low calcium stimulation of 1-OHase in HCD cells
was sustained, with levels significantly higher at 24 hours
and still elevated at 48 hours. Regulation of 24-OHase
activity paralleled that observed with 1-OHase. As with
1-OHase, low calcium induction of 24,24(OH)2D3 pro-
duction was transient in HKC-8 cells, but sustained inFig. 1. Expression of 1-OHase and calciotropic receptor mRNA and
protein in SV40-transformed human proximal tubule (HKC-8) and hu- the HCD (Fig. 3B).
man collecting duct (HCD) cell lines. RT-PCR analyses using primers Recent studies have shown that the mitogen LPS in-specific for 1-OHase produced a single band of 542 bp corresponding
duces potent inflammatory responses in the kidney thatto renal 1-OHase in both HKC-8 and HCD cells (, negative control;
A). RT-PCR analyses using primers specific for parathyroid hormone appear to be regional and CD14-dependent [21]. With
(PTH) receptor types 1 or 2 demonstrated mRNA encoding PTH receptor this in mind, further studies were carried out to assesstype 1 (B) and type 2 (C) in both cell lines (, negative control). Western
the effect of LPS on vitamin D metabolism in HCD andblot analysis of cell lysates [1-OHase, 3 g/lane; human calcium recep-
tor (CaR), 10 g/lane] or nuclear proteins [human vitamin D receptor HKC-8 cells. Results in Figure 4 show a striking induction
(VDR), 10 g/lane] using a polyclonal antibody specific for 1-OHase of 1-OHase activity in HCD cells following incubationor specific monoclonal antibodies (CaR, VDR) confirmed the presence
with LPS (1 g/mL). Activity was induced fourfold afterof 1-OHase protein (D), the CaR protein (E ), and indicated that
HKC-8 and HCD cells expressed similar levels of VDR (F ). 24 hours of incubation increasing to 20-fold after 48
hours. In contrast, LPS elicited only a small (2.5-fold,
at 48 hours), nonsignificant induction in HKC-8 cells
(Fig. 4A). This was consistent with the presence in HCD
lines (Fig. 1E). However, in addition to the expected cells of mRNA encoding both CD14 (LPS receptor) and
120 kD CaR, HCD cells also expressed a larger protein Toll-like receptor 4 (Tlr4; Fig. 5). Although RT-PCR
species. Both Western blots (Fig. 1F) and parallel ligand analysis indicated that HKC-8 cells also express CD14
binding studies (data not shown) indicated that HKC-8 mRNA, the presence of Tlr4 mRNA, which is necessary
and HCD cells expressed similar levels of vitamin D for intact LPS signaling, was not apparent (Fig. 5). 24-
receptors (VDR). OHase activity showed only a slight, nonsignificant in-
Analysis of [3H]-25OH2D3 metabolism by intact HKC-8 crease following LPS treatment in the HCD cells and
and HCD cells using TLC separation, followed by quan- was unaltered in the HKC-8 cells (Fig. 4B). Induction
titative scanning analysis of metabolites, demonstrated of 1-OHase also was observed in HCD cells treated
1- and 24-OHase activity in both cell lines. Basal activity with tumor necrosis factor- (TNF; 30 ng/mL). This
of 1-OHase in HKC-8 cells (400.3  43.8 fmol/mg/h) effect was more modest than observed for LPS [1.5-fold
was approximately 5.8-fold higher than that in HCD cells increase in 1,25(OH)2D3 production compared with con-
(68.9 26.5 fmol/mg/h). However, 24-OHase activity was trol at 24 and 48 hours]. However, as with LPS, this re-
more than twofold higher in HCD cells (HCD 1323 213 sponse was specific for HCD cells and no parallel induc-
fmol/mg/h vs. HKC-8 624 68.4 fmol/mg/h). Synthesis of tion of 24-OHase activity was observed (data not shown).
1,25(OH)2D3 was significantly increased by forskolin (10 Further studies were carried out to assess the feedback
mol/L, 24 h) and PTH (100 ng/mL, 24 hours) in both regulation of 1,25(OH)2D3 production in HKC-8 and HCD
cell lines (Fig. 2 A, B). In contrast, induction of 1-OHase cells. In both cell lines, cotreatment with 1,25(OH)2D3
completely abolished PTH (1-34) induction of 1-OHase,activity by calcitonin (100 mol/L, 24 hours) was ob-
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Fig. 2. Regulation of 1- and 24-OHase activities in HKC-8 and HCD cells. Regulation of 1-OHase activity in HKC-8 cells (A) and HCD cells
(B). Regulation of 24-OHase activity in HKC-8 (C) and HCD (D) cells. Cells were treated for 24 hours with 10 mol/L forskolin, 10 nmol/L
1,25(OH)2D3, 100 ng/mL PTH, and 100 mol/L calcitonin. [3H]-25OHD3 was included for the final four hours. Data are shown as the production
of 1,25(OH)2D3 (1-OHase activity) or 24,25(OH)2D3 (24-OHase activity). Results represent mean  SEM; N  3–8. *P 	 0.05; **P 	 0.01; vs.
control.
whereas low calcium induction of 1-OHase was only meostasis by stimulating dietary calcium uptake by the
gastrointestinal tract. However, in view of the fact thatsuppressed by 1,25(OH)2D3 in HCD cells. Conversely, the
increased 1-OHase activity observed in HCD cells follow- PCT cells also act as the major site of calcium and phos-
phate reabsorption, local expression of 1-OHase alsoing treatment with LPS was unaffected by cotreatment
with 1,25(OH)2D3 but reduced in HKC-8 cells (Fig. 6). may support autocrine responses. Both calcium and phos-
phate reabsorption may be modulated by 1,25(OH)2D3
through regulation of the CaR [23] and sodium-phos-
DISCUSSION phate cotransport protein [24] expression, respectively.
Although original studies identified the proximal tu- However, further analysis of renal vitamin D metabolism
bules as the main site of renal vitamin D metabolism, it in humans has been limited due to the lack of availability
is now clear that expression of both 1- and 24-OHase of suitable in vitro models. Our study used transformed
occurs throughout the nephron [17, 22]. This has raised human PCT and CCD cell lines to investigate the possi-
important new questions concerning the possible site- ble differential regulation of 1-OHase and 24-OHase
specific functions of renal vitamin D metabolism and, in along the nephron.
particular, synthesis of the active form of vitamin D, Initial RT-PCR and Western blot analyses confirmed
1,25(OH)2D3. Studies using vitamin D-depleted animals the presence of 1-OHase in both HKC-8 and HCD
support the endocrine role of PTH-stimulated PCT cells cells, although the level of enzyme activity was lower in
in maintaining circulating levels of 1,25(OH)2D3 during HCD than in HKC-8 cells. Regulation of 1-OHase activ-
vitamin D insufficiency [14, 15]. In this way, renal synthe- ity by agents such as forskolin, PTH, and 1,25(OH)2D3
was similar for both cell lines. However, in contrast tosis of 1,25(OH)2D3 has an indirect effect on calcium ho-
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Fig. 3. Regulation of 1- and 24-OHase ac-
tivity by low calcium medium. Regulation of
1-OHase (A) and 24-OHase (B) activity by
medium containing low calcium concentrations.
Cells were incubated in 0.5 mmol/L calcium
for 4, 24 or 48 hours or normal medium calcium
(1 mmol/L; Control). [3H]-25OHD3 was in-
cluded for the final four hours. Data are shown
as the production of 1,25(OH)2D3 (1-OHase
activity) or 24,25(OH)2D3 (24-OHase activity).
Results represent mean  SEM; N  3 to 4.
*P 	 0.05; **P 	 0.01; ***P 	 0.001; vs. con-
trol.
HKC-8 cells, synthesis of 1,25(OH)2D3 by HCD cells induction. The potent induction of 1-OHase in HCD
cells by LPS is similar to that previously described foralso was stimulated by calcitonin. This is consistent with
previous in vivo studies in which calcitonin increased the macrophages, a key extrarenal source of 1,25(OH)2D3
[29, 30]. In view of the proposed antiproliferative/immuno-expression and activity of 1-OHase in rats [25]. This
response occurred under normocalcemic conditions and modulatory actions of macrophage-derived 1,25(OH)2D3
[31], it is possible to speculate that in the distal nephron,appeared to be due to induction of 1-OHase in sections
of the nephron that were distal to the PCT. In contrast, 1-OHase fulfills a similar function. Irrespective of the
likely exposure of kidney epithelial cells to LPS, our dataPTH induction of 1-OHase occurred only in vitamin
D-deficient animals [25]. The precise role of 1-OHase in are consistent with several reports that have highlighted
the renal expression of CD14, a cell surface glycosylphos-CCD cells remains unclear. Previous studies have shown
that 1,25(OH)2D3, as well as calcitonin and PTH, is able to phatidylinositol-linked protein that binds LPS bound to
extracellular LPS-binding protein [32, 33]. CD14 is a keyregulate calcium absorption in the distal nephron [26, 27].
Alternatively, local synthesis and action of 1,25(OH)2D3 marker of mature monocytes (including macrophages),
although previous reports have shown that it also is de-may fulfill noncalciotropic functions. For example, stud-
ies have shown that, unlike PTH, 1,25(OH)2D3 stimulates tectable in the kidney. Immunohistochemistry indicates
that CD14 is relatively weakly expressed in the renalexpression of the sodium-sulfate cotransporter protein,
with vitamin D-deficient animals showing abnormal sul- cortex but is more abundant in the medulla [21]. More
importantly, recent studies have highlighted the induc-fate metabolism [28].
The most striking difference between HKC-8 and HCD tion of CD14 expression in renal epithelial cells during
renal disease [32]. In that particular study, the authorscells was the responsiveness of the latter to immunoactive
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Fig. 4. Regulation of 1-OHase (A) and 24-
OHase (B) activity by lipopolysaccharide
(LPS). Cells were incubated in (1g/mL) LPS
for 24 or 48 hours. [3H]-25OHD3 was included
for a further four hours in serum-free defined
medium. Data are shown as the produc-
tion of 1,25(OH)2D3 (1-OHase activity) or
24,25(OH)2D3 (24-OHase activity). Results
represent mean  SEM; N  3 to 4. **P 	
0.01; vs. control.
hypothesized that CD14 expression along the nephron which is required for transduction of CD14 signaling
[36]. In this respect, CD14-mediated regulation of 1-may act to bind agents such as ceramide or inositol phos-
pholipids, leading to eventual renal tubular apoptosis. OHase in HCD cells may provide an invaluable model
system for assessing the divergence between renal andThe precise mechanism by which the induction of 1-
OHase interacts with CD14 signaling remains to be deter- extrarenal 1,25(OH)2D3 production. Specifically, the ap-
parent lack of self-regulation of 1-OHase observed inmined, although previous studies have described both pro-
apoptotic and anti-apoptotic actions for 1,25(OH)2D3 cells such as macrophages initially suggested a different
gene product. However, recent cloning studies have re-[34, 35]. Although this represents autocrine activation
of cellular responses to 1,25(OH)2D3, it is possible that vealed the same mRNA for 1-OHase in renal and extra-
renal tissues [11, 12], and have identified several nuclearCD14-induced 1-OHase also mediates paracrine re-
sponses. In particular, local synthesis of 1,25(OH)2D3 factor-
B (NF-
B) response elements in the promoter
region of the gene for 1-OHase [37]. Hence, it was inter-may act by modulating invading lymphocytes, as pre-
viously described for lymphoid tissues [31]. RT-PCR esting to note that, unlike PTH induction, the LPS-stimu-
lated 1,25(OH)2D3 production in HCD cells was insensi-analyses showed that mRNA for CD14 was expressed
in both HKC-8 and HCD cells. This was supported by tive to feedback regulation by 1,25(OH)2D3 itself. In
view of the inherent difficulties in carrying out promoter-preliminary flow cytometry, which showed similar levels
of CD14 immunoreactivity (data not shown). Therefore reporter analyses in macrophages, HCD cells may pro-
vide a novel and potentially important system for as-it appears that the LPS-responsiveness in HCD cells is
due to selective expression of Toll-like receptor 4 (Tlr4), sessing CD14-Tlr4–mediated signaling, particularly with
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itself through VDR-modulated transcriptional regula-
tion. The fact that both cell lines expressed similar num-
bers of VDR suggests that alternative mechanisms are
involved in the reciprocal relationship between 1- and
24-OHase activities in HKC-8 and HCD cells. For ex-
ample, the uptake of 25(OH)D3, and to a lesser extent
1,25(OH)2D3, is facilitated by the glycoprotein gp330,
also known as megalin [38]. Megalin has been immunolo-
calized to a variety of human tissues, particularly the
proximal tubules. In addition, megalin-null mice were
reported to have low levels of circulating 1,25(OH)2D3,
leading in turn to rickets [39, 40]. Collectively, these data
indicate that variations in megalin expression may play
a significant role in determining tissue-specific uptake of
vitamin D metabolites. It was therefore interesting to
note that although 1,25(OH)2D3 production was much
higher in HKC-8 cells, synthesis of 24,25(OH)2D3 was
higher in HCD cells. This suggests that both cell lines
have a similar capacity for the uptake of 25OHD3. Thus,
at least in vitro, it is still unclear whether megalin is a
major determinant of tissue specific differences in 1-
OHase activity.
It also seems likely that site-specific differences in re-
nal 1-OHase and 24-OHase activities will reflect varia-
tions in either calcium sensing or PTH responses. This
is perhaps best illustrated by the sustained induction of
1-OHase in low calcium-treated HCD cells, suggestingFig. 5. Expression of CD14 and Toll-like receptor 4 (Tlr4) mRNA. RT-
PCR analyses using primers specific for CD14 and Tlr4 demonstrated that these cells have a different calcium-sensing response.
mRNA encoding CD14 molecules in both cell lines, but mRNA encod- It is interesting to note that in addition to the expecteding Tlr4 was only detected in HCD cells. Tlr4 expression was not altered
CaR protein species in HCD cells, a larger species wasfollowing incubation in LPS (1 g/mL, 48 hours). 18S rRNA expression
was included to demonstrate intact mRNA. also detected by Western blot analysis. Additionally, the
polarity of the CaR varies throughout the nephron. The
CaR is located on the apical membrane in the brush
border of the PCT, but is generally located on the baso-
respect to the analysis of renal and extrarenal 1-OHase lateral membrane in the distal nephron [41]. The impact
expression. of these different locations on the differential regulation
An important observation from the analysis of HKC-8 of 1-OHase in vitro and in vivo remains unclear, but
and HCD cells is the apparent lack of correlation between suggests alternative functions for calcium sensing in PCT
expression of mRNA and protein for 1-OHase and and CCD cells. In particular, it will be important in future
actual capacity for 1,25(OH)2D3 production. In previous studies to clarify the mechanisms associated with the
in situ hybridization and immunohistochemistry studies, integration of CaR and NF-
B–mediated signaling along
we have shown that 1-OHase is strongly expressed in the nephron. Recent reports have suggested that the rela-
more distal areas of the human nephron [17]. Conversely, tively high concentrations of extracellular calcium at sites
in data shown here, synthesis of 1,25(OH)2D3 by PCT of injury or infection may contribute to immune responses.
HKC-8 cells was more than fivefold higher than in HCD Specifically, treatment with increased extracellular cal-
cells despite the fact that both lines expressed similar cium or a CaR antagonist was shown to modulate innate
levels of mRNA and protein for 1-OHase. It therefore immune responses by enhancing monocyte chemotaxis
seems clear that mechanisms other than transcriptional [42]. Thus, in view of its well-established role as an immu-
control can act to modulate renal 1-OHase activity. nosuppressive agent, it is possible to speculate that local
This may be due in part to increased expression of 24- synthesis of 1,25(OH)2D3 may act as a link between im-
OHase in HCD cells, which in turn would lead to the mune and CaR-mediated responses in renal cells.
attenuation of local levels of 1,25(OH)2D3 either by con- Data presented in this study provide further evidence
verting the active metabolite to 1,24,25(OH)3D3 or by for the synthesis of 1,25(OH)2D3 at various sites along
competing with 1-OHase for substrate (25(OH)D3). Ex- the nephron. Although it is important to exercise caution
in extrapolating observations from transformed cells, re-pression of 24-OHase is normally induced by 1,25(OH)2D3
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Fig. 6. Autoregulation of 1-OHase and 24-
OHase activity by 1,25(OH)2D3 in HKC-8 cells
(A) and HCD cells (B). Cells were incubated
with 0.5 mmol/L calcium for 4 hours, 100 ng/mL
PTH for 24 hours, or 1 g/mL LPS for 48
hours alone, or in combination with 10 nmol/L
1,25(OH)2D3 for 24 hours (low Ca and PTH)
or 48 hours (LPS). Dashed line represents rel-
ative enzyme activity following treatment with
1,25(OH)2D3 alone. Results represent mean 
SEM relative to a control value of 1 (Con);
N  3 to . *P 	 0.05; **P 	 0.01; NS, nonsig-
nificant.
and P. Goldsmith (Metabolic Diseases Branch, NIDDK/NIH) forsults from HCD and HKC-8 cells support possible alter-
allowing us to use the calcium-sensing receptor antibody. R.B is a
native roles for 1-OHase at proximal versus distal sites. National Kidney Research Fund Fellow, and P.M.S is an MRC Senior
In particular, we have shown, to our knowledge for the Clinical Fellow.
Editor’s note: Prof. Eberhard Ritz served as Guest Editor duringfirst time, that renal synthesis of 1,25(OH)2D3 can be in-
the peer review process of this manuscript.
duced by an immunological stimulus. This may act as a
novel model system for dissecting the differential regula- Reprint requests to Martin Hewison, Ph.D., Division of Medical
Sciences, The University of Birmingham, Queen Elizabeth Hospital,tion of 1-OHase by calciotropic and inflammatory agents.
Edgbaston, Birmingham B15 2TH, England, United Kingdom.More importantly, data also suggest that activation of E-mail: m.hewison@bham.ac.uk
vitamin D by CCD cells is part of the mechanism by
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